See page five Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs
CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding
Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues
HR 436/ S 17, Protect Medical Innovation Act of 2011
HR 488, Save Our Medical Devices Act of 2011
HR 755, Investing in Our Future Act of 2011
HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011
S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 See page seven Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs
CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding
Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues
HR 436/ S 17, Protect Medical Innovation Act of 2011
HR 488, Save Our Medical Devices Act of 2011
HR 755, Investing in Our Future Act of 2011
HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011
S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011 See page three Lobbying Issues: Molecular diagnostic tests, Infection control and prevention programs (Multidrug resistant organisms (MDRO)), CDC-related issues (MDRO research and surveillance), Hospital and other provider quality improvement programs
CMS-related issues (reimbursement and coverage policies), FDA oversight, Global health funding
Comparative effectiveness, Personalized medicine/pharmacogenomics, Veterans Affairs healthcare-related issues
HR 436/ S 17, Protect Medical Innovation Act of 2011
HR 488, Save Our Medical Devices Act of 2011
HR 755, Investing in Our Future Act of 2011
HR 965, Preservation of Antibiotics for Medical Treatment Act of 2011
S 660, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2011
MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid HCR - Health Issues
132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 39 - State, Dept of (DOS) 132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 39 - State, Dept of (DOS) 132 - Agency for Healthcare Research & Quality (AHRQ) 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 135 - Food & Drug Administration (FDA) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 1 - SENATE 39 - State, Dept of (DOS)
CEPHEID
2200 Pennsylvania Ave NW, Suite 800 W, Washington, DC, DC, 20037, US
MICHELE M SCHOONMAKER HALLIE CHRISTINE LEWIS MICHELE M SCHOONMAKER HALLIE CHRISTINE LEWIS MICHELE M SCHOONMAKER HALLIE CHRISTINE LEWIS